| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |